Altre lingue Spectral Medical Inc.

Azioni

EDT

CA8475771033

Mercato chiuso - Toronto S.E. Altri mercati azionari 15:57:45 24/04/2024			Variaz. 5gg	Var. 1 gen.
0,425 ^CAD	-3,41%		-3,41%	0,00%

10/04	Spectral Medical fornisce un aggiornamento sullo studio Tigris	CI
02/04	Spectral Medical Inc. annuncia cambiamenti nel Consiglio di Amministrazione	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Spectral Medical Updated on Tigris Trial	10/04
Spectral Medical Brief: Providing Tigris Trial Update; 101 patients enrolled	10/04
Spectral Medical Provides Tigris Trial Update	10/04
Spectral Medical Provides Tigris Trial Update	10/04
North American Morning Briefing : Investors on -2-	05/04
Spectral Medical Brief: Paul Walker will immediately succeed Bihl as Chair	02/04
Spectral Medical Brief: Anthony Bihl III, Spectral's Chairman, will be retiring from the Board at Upcoming Shareholder Meeting in June 2024	02/04
Spectral Medical Chair to Retire From the Board of Directors	02/04
Spectral Medical Inc. Announces Board Changes	02/04
Spectral Medical Brief: Says Total of 97 patients randomized to date out of the 150 total patients to be enrolled in the Tigris trial	28/03
Spectral Medical Brief: Q4 Revenue $365,000; Loss was $6,479,000, or $0.02 per share	28/03
Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update	28/03
Spectral Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
North American Morning Briefing : Stocks Struggle After New Records	22/03
Spectral Medical Provides February Tigris Trial Update	28/02
Spectral Medical Inc. Provides Update on the Company's Tigris Trial	28/02
Spectral Medical Brief: Providing February Tigris Trial Update; 93 patients enrolled; February represents a second record breaking consecutive month for patient enrollment	28/02
Spectral Medical Provides February Tigris Trial Update	28/02
Spectral Medical Says PMX Distribution and Supply Agreement with Baxter International Extended for 10 Years	21/02
Spectral Medical Brief: Baxter to act as Exclusive partner to Spectral for 10 years following PMX approval by U.S. FDA	21/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Spectral Medical Inc.

Azioni

EDT

CA8475771033

Altre lingue

Filtri